Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Targeting CD24 activates macrophages to reduce tumor burden in preclinical models of solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 02, 2026
Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 02, 2026
Ovarian Cancer Ascites Enriched for CCL23 Reduces Macrophage-Derived CXCL10 Secretion and Is Associated with Poor Patient Outcomes.
Journal: Cancers
Published: October 31, 2025
Uterine serous carcinoma and germline genetic testing: patterns of referral, completion and pathogenic variant detection.
Journal: Journal of medical genetics
Published: October 10, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 13, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 13, 2025
Active Forms of Chemerin Are Elevated in Human and Mouse Ovarian Carcinoma.
Journal: Biomedicines
Published: February 27, 2025
Early experience and assessment of real-world toxicities with mirvetuximab soravtansine in a heavily pretreated patient cohort with ovarian cancer.
Journal: Gynecologic oncology reports
Published: February 20, 2025
Fertility-sparing treatment for atypical polypoid adenomyoma.
Journal: Gynecologic oncology reports
Published: January 26, 2025
Long term treatment of advanced endometrial cancer with lenvatinib and pembrolizumab.
Journal: Gynecologic oncology reports
Published: January 20, 2025
Clinical Response to Enfortumab Vedotin and Pembrolizumab in a Patient with Vaginal Squamous Cell Carcinoma: A Case Report.
Journal: Case reports in oncology
Published: December 12, 2024
Last Updated: 09/26/2026